Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06215040

The Treatment Effect for Asymptomatic Common Bile Duct Stone

Multicenter Prospective Study for Efficacy of Asymptomatic Common Bile Duct Stone Treatment

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.

Detailed description

There is no conflcts for treatment of symptomatic common bile duct stone. As more imaging examination such as healthy screening, more asymptomatic common bile duct stone patients are found. Current guideline for aymptomatic common bile duct stone is removal using endoscopic retrograde cholangiopancreatography. However, the previous studies that support this guideline included patients who just underwent cholecystectomy and were diagnosed as common bile duct stone. There is no prospective study for identify the treatment effectiveness of common bile duct stone removal in asymptomatic patients who are dignosed in healthy screening. Therefore, we are going to find the effectiveness of common bile duct stone removal by comparing questionnarie before and after removal of common bile duct stone in asymptomatic and incidentally found common bile duct stone patients. In addition, we are going to follow up patients who do not want to undergo common bile duct stone removal and find the rate of cholangitis risk. We also want to identify extact complication rate for endoscopic retrograde pancreatocholangiographic procedures in asymptomatic common bile duct stone.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic retrograde cholangiopancratographycommon bile duct stone removal

Timeline

Start date
2024-01-02
Primary completion
2027-12-31
Completion
2028-12-31
First posted
2024-01-22
Last updated
2024-01-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06215040. Inclusion in this directory is not an endorsement.